Cargando…
The dynamic wound microbiome
BACKGROUND: Diabetic foot ulcers (DFUs) account for the majority of all limb amputations and hospitalizations due to diabetes complications. With 30 million cases of diabetes in the USA and 500,000 new diagnoses each year, DFUs are a growing health problem. Diabetes patients with limb amputations ha...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685579/ https://www.ncbi.nlm.nih.gov/pubmed/33228639 http://dx.doi.org/10.1186/s12916-020-01820-6 |
_version_ | 1783613203809304576 |
---|---|
author | Liu, Chunan Ponsero, Alise J. Armstrong, David G. Lipsky, Benjamin A. Hurwitz, Bonnie L. |
author_facet | Liu, Chunan Ponsero, Alise J. Armstrong, David G. Lipsky, Benjamin A. Hurwitz, Bonnie L. |
author_sort | Liu, Chunan |
collection | PubMed |
description | BACKGROUND: Diabetic foot ulcers (DFUs) account for the majority of all limb amputations and hospitalizations due to diabetes complications. With 30 million cases of diabetes in the USA and 500,000 new diagnoses each year, DFUs are a growing health problem. Diabetes patients with limb amputations have high postoperative mortality, a high rate of secondary amputation, prolonged inpatient hospital stays, and a high incidence of re-hospitalization. DFU-associated amputations constitute a significant burden on healthcare resources that cost more than 10 billion dollars per year. Currently, there is no way to identify wounds that will heal versus those that will become severely infected and require amputation. MAIN BODY: Accurate identification of causative pathogens in diabetic foot ulcers is a critical component of effective treatment. Compared to traditional culture-based methods, advanced sequencing technologies provide more comprehensive and unbiased profiling on wound microbiome with a higher taxonomic resolution, as well as functional annotation such as virulence and antibiotic resistance. In this review, we summarize the latest developments in defining the microbiology of diabetic foot ulcers that have been unveiled by sequencing technologies and discuss both the future promises and current limitations of these approaches. In particular, we highlight the temporal patterns and system dynamics in the diabetic foot microbiome monitored and measured during wound progression and medical intervention, and explore the feasibility of molecular diagnostics in clinics. CONCLUSION: Molecular tests conducted during weekly office visits to clean and examine DFUs would allow clinicians to offer personalized treatment and antibiotic therapy. Personalized wound management could reduce healthcare costs, improve quality of life for patients, and recoup lost productivity that is important not only to the patient, but also to healthcare payers and providers. These efforts could also improve antibiotic stewardship and control the rise of “superbugs” vital to global health. |
format | Online Article Text |
id | pubmed-7685579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76855792020-11-25 The dynamic wound microbiome Liu, Chunan Ponsero, Alise J. Armstrong, David G. Lipsky, Benjamin A. Hurwitz, Bonnie L. BMC Med Review BACKGROUND: Diabetic foot ulcers (DFUs) account for the majority of all limb amputations and hospitalizations due to diabetes complications. With 30 million cases of diabetes in the USA and 500,000 new diagnoses each year, DFUs are a growing health problem. Diabetes patients with limb amputations have high postoperative mortality, a high rate of secondary amputation, prolonged inpatient hospital stays, and a high incidence of re-hospitalization. DFU-associated amputations constitute a significant burden on healthcare resources that cost more than 10 billion dollars per year. Currently, there is no way to identify wounds that will heal versus those that will become severely infected and require amputation. MAIN BODY: Accurate identification of causative pathogens in diabetic foot ulcers is a critical component of effective treatment. Compared to traditional culture-based methods, advanced sequencing technologies provide more comprehensive and unbiased profiling on wound microbiome with a higher taxonomic resolution, as well as functional annotation such as virulence and antibiotic resistance. In this review, we summarize the latest developments in defining the microbiology of diabetic foot ulcers that have been unveiled by sequencing technologies and discuss both the future promises and current limitations of these approaches. In particular, we highlight the temporal patterns and system dynamics in the diabetic foot microbiome monitored and measured during wound progression and medical intervention, and explore the feasibility of molecular diagnostics in clinics. CONCLUSION: Molecular tests conducted during weekly office visits to clean and examine DFUs would allow clinicians to offer personalized treatment and antibiotic therapy. Personalized wound management could reduce healthcare costs, improve quality of life for patients, and recoup lost productivity that is important not only to the patient, but also to healthcare payers and providers. These efforts could also improve antibiotic stewardship and control the rise of “superbugs” vital to global health. BioMed Central 2020-11-24 /pmc/articles/PMC7685579/ /pubmed/33228639 http://dx.doi.org/10.1186/s12916-020-01820-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Liu, Chunan Ponsero, Alise J. Armstrong, David G. Lipsky, Benjamin A. Hurwitz, Bonnie L. The dynamic wound microbiome |
title | The dynamic wound microbiome |
title_full | The dynamic wound microbiome |
title_fullStr | The dynamic wound microbiome |
title_full_unstemmed | The dynamic wound microbiome |
title_short | The dynamic wound microbiome |
title_sort | dynamic wound microbiome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685579/ https://www.ncbi.nlm.nih.gov/pubmed/33228639 http://dx.doi.org/10.1186/s12916-020-01820-6 |
work_keys_str_mv | AT liuchunan thedynamicwoundmicrobiome AT ponseroalisej thedynamicwoundmicrobiome AT armstrongdavidg thedynamicwoundmicrobiome AT lipskybenjamina thedynamicwoundmicrobiome AT hurwitzbonniel thedynamicwoundmicrobiome AT liuchunan dynamicwoundmicrobiome AT ponseroalisej dynamicwoundmicrobiome AT armstrongdavidg dynamicwoundmicrobiome AT lipskybenjamina dynamicwoundmicrobiome AT hurwitzbonniel dynamicwoundmicrobiome |